Scientists test drug combo to shrink tumors before surgery
NCT ID NCT06561308
Summary
This study is testing whether giving a combination of chemotherapy and an immunotherapy drug (camrelizumab) before surgery can help shrink tumors in people with advanced endometrial cancer. The goal is to see if this approach makes surgery more successful and helps patients live longer. Researchers will enroll 39 patients with stage III or IV cancer to measure tumor response, surgery outcomes, and survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOID ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Women's hospital school of medicine zhejiang university
RECRUITINGHangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.